封面
市場調查報告書
商品編碼
1490078

潤喉糖市場:按產品類型、按適應症、按類型、按分銷管道、按地區

Throat Lozenges Market, By Product Type, By Indication, By Type, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球潤喉糖市場規模為45.9億美元,預計到2031年將達68億美元,2024年至2031年年複合成長率為5.8%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 45.9億美元
實際資料 2019-2023 預測期 2024年至2031年
預測 2024-2031 年年複合成長率: 5.80% 2031年價值預測 68億美元
圖:2024 年按地區分類的潤喉糖市場佔有率(%)
潤喉糖市場-IMG1

潤喉糖是一種藥用糖果或錠劑,旨在緩解喉嚨發炎和疼痛。感冒、咳嗽和其他咽喉感染疾病的區域性爆發正在推動對咽喉含片的需求。健康意識的提高和對快速緩解非處方藥的偏好預計將推動市場成長。潤喉糖越來越受歡迎,因為它們有多種口味以滿足消費者的口味。然而,一些新興國家缺乏替代治療方案和認知可能會阻礙市場成長。

市場動態:

由於生活方式和氣候條件的變化,喉嚨感染疾病的盛行率不斷上升,推動了全球潤喉糖市場的成長。都市區污染程度的上升增加了城市居民患發炎的風險,而繁忙的日程和增加的壓力水平削弱了免疫力。因此,人們越來越需要在無需醫療干涉的情況下快速緩解喉嚨痛,潤喉糖的銷售量也不斷增加。然而,過量攝取潤喉糖的副作用以及喉嚨噴霧劑和漱口劑等替代療法的出現阻礙了市場的成長。公司正在探索推出有機和草藥產品的機會,以滿足注重健康的消費者的需求。專注於這些含片的新口味可以為市場成長提供新的機會。

本研究的主要特點

  • 該報告對全球潤喉糖市場進行了詳細分析,以2023年為基準年估計了預測期(2024-2031年)的市場規模(十億美元)和年複合成長率(CAGR%)。
  • 它還揭示了各個細分市場的潛在收益成長機會,並說明了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數,介紹了全球喉糖市場的主要企業。
  • 主要企業包括Novartis AG、Cipla、Procter & Gamble、GSK plc、Sanofi、Lozen Pharma、Bliss GVS Pharma Ltd.、Honibe、Ricola、Prestige Consumer Healthcare Inc.、Traditional Medicinals, Inc.、MondelA "z International、Inova Pharmaceuticals 、 Johnson &Johnson Services, Inc. 與利潔時集團 PLC。
  • 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球潤喉糖市場迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球喉糖市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球潤喉糖市場-冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章全球潤喉糖市場,依產品類型,2019-2031

  • 硬糖含片
  • 軟菱形
  • 壓縮錠劑

第6章 全球潤喉糖市場,依適應症分類,2019-2031 年

  • 喉嚨痛
  • 咳嗽和感冒
  • 喉嚨疾病

第7章全球潤喉糖市場,依類型,2019-2031

  • OTC
  • 處方箋

第8章全球潤喉糖市場,依通路,2019-2031

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 全球喉滴劑市場,依地區分類,2019-2031

第10章競爭格局

  • 公司簡介
    • Novartis AG
    • Cipla
    • Procter &Gamble
    • GSK plc
    • Sanofi
    • Lozen Pharma
    • Bliss GVS Pharma Ltd.
    • Honibe
    • Ricola
    • Prestige Consumer Healthcare Inc.
    • Traditional Medicinals, Inc
    • Mondelez International
    • Inova Pharmaceuticals
    • Johnson &Johnson Services, Inc.
    • Reckitt Benckiser Group PLC

第11章分析師建議

  • Wheel of Fortune
  • 分析師觀點
  • Coherent Opportunity Map

第12章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI6975

Global throat lozenges market is estimated to be valued at USD 4.59 Bn in 2024 and is expected to reach USD 6.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 4.59 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 5.80% 2031 Value Projection: US$ 6.80 Bn
Figure. Throat Lozenges Market Share (%), By Region 2024
Throat Lozenges Market - IMG1

Throat lozenges are medicated candies or tablets that are intended to relieve throat irritation and soreness. Factors such as increasing prevalence of common cold, cough and other throat infections across regions boosts demand for throat lozenges. Rising health awareness and preference for over-the-counter medications for quick relief are expected to drive the market growth. The availability of throat lozenges in a wide range of flavors, catering to different consumer preferences, has boosted their popularity. However, alternative treatment options and lack of awareness in some emerging nations can hamper the market growth.

Market Dynamics:

Global throat lozenges market growth is driven by growing incidence of throat infections due to changing lifestyles and climatic conditions. Rising pollution levels in urban areas have increased the risk of throat irritation among city dwellers and busy schedules and higher stress levels have weakened immunity. This has boosted the need for fast relief from throat problems without medical intervention, thus, boosting sales of throat lozenges. However, factors such as side-effects of excessive lozenge intake and availability of alternative treatment in the form of throat sprays and gargles hampers the market growth. Companies are exploring opportunities to launch organic and herbal formulations to cater to health-conscious consumers. Focus on new flavors of these lozenges can offer new opportunities for the market growth.

Key Features of the Study:

  • This report provides an in-depth analysis of the global throat lozenges market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global throat lozenges market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Novartis AG, Cipla, Procter & Gamble, GSK plc, Sanofi, Lozen Pharma, Bliss GVS Pharma Ltd., Honibe, Ricola, Prestige Consumer Healthcare Inc., Traditional Medicinals, Inc, MondelA"z International, Inova Pharmaceuticals, Johnson & Johnson Services, Inc., Reckitt Benckiser Group PLC.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global throat lozenges market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global throat lozenges market.

Detailed Segmentation-

  • By Product Type:
    • Hard candy lozenges
    • Soft lozenges
    • Compressed lozenges
  • By Indication:
    • Sore throat
    • Cough and Cold
    • Throat diseases
  • By Type:
    • OTC
    • Prescription
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Novartis AG
    • Cipla
    • Procter & Gamble
    • GSK plc
    • Sanofi
    • Lozen Pharma
    • Bliss GVS Pharma Ltd.
    • Honibe
    • Ricola
    • Prestige Consumer Healthcare Inc.
    • Traditional Medicinals, Inc
    • MondelA"z International
    • Inova Pharmaceuticals
    • Johnson & Johnson Services, Inc.
    • Reckitt Benckiser Group PLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Indication
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Throat Lozenges Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Throat Lozenges Market, By Product Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hard candy lozenges
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Soft lozenges
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Compressed lozenges
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Throat Lozenges Market, By Indication, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Sore throat
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cough and Cold
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Throat diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Throat Lozenges Market, By Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • OTC
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Prescription
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Throat Lozenges Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Throat Lozenges Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cipla
    • Procter & Gamble
    • GSK plc
    • Sanofi
    • Lozen Pharma
    • Bliss GVS Pharma Ltd.
    • Honibe
    • Ricola
    • Prestige Consumer Healthcare Inc.
    • Traditional Medicinals, Inc
    • Mondelez International
    • Inova Pharmaceuticals
    • Johnson & Johnson Services, Inc.
    • Reckitt Benckiser Group PLC

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact